Patent Yard Sign in
Canadian application, no grantCanada

Lithium treatment

CA 2052246 A1 · Owner: Horrobin, David Frederick · Inventors: Horrobin, David Frederick

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Lithium Treatment, The present invention provides a topical pharmaceutical composition for use in the treatment and/or prophylaxis of Molluscum Contagiosum said, composition comprising a physiologically acceptable lithium compound together with at least one pharmaceutically acceptable carrier or excipient. It also extends to pharmaceutical compositions comprising a physiologically acceptable lithium compound together with at least one keratolytic and/or skin penetration assisting agent and at least one pharmaceutically acceptable carrier or excipient.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 25, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 25, 1991
GrantedNo grant recorded
Term endedSeptember 25, 2011
Patent numberCA 2052246 A1
Classification (IPC)A61K31/19 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedSep 25, 1991Term endedSep 25, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.